Literature DB >> 12483464

The K121Q polymorphism in the plasma cell membrane glycoprotein 1 gene predisposes to early myocardial infarction.

Georg Endler1, Christine Mannhalter, Heike Sunder-Plassmann, Martin Schillinger, Alexandra Klimesch, Markus Exner, Sonja Kapiotis, Susanne Meier, Freja Kunz, Elisabeth Raiger, Kurt Huber, Oswald Wagner, Raute Sunder-Plassmann.   

Abstract

Elevated plasma cell membrane glycoprotein 1 (PC-1) expression and the frequent PC-1 K121Q polymorphism have recently been associated with insulin resistance. Since insulin resistance represents an important risk factor for atherosclerotic vascular disease and myocardial infarction, we investigated the involvement of the PC-1 K121Q polymorphism in the development of myocardial infarction. We analyzed two independent series of cardiovascular patients at a defined end-point of atherosclerotic vascular disease (those having suffered myocardial infarction) for the PC-1 K121Q mutation by a newly developed mutagenic separated PCR assay. In both patient groups the presence of the Q allele was significantly associated with younger age at the time of first myocardial infarction, suggesting a more rapid progression of endothelial dysfunction. In a multivariate analysis carriers of the 121Q allele from Vienna and from Central Germany exhibited a 2.6- and a 4.2-increased odds, respectively, for suffering myocardial infarction within the first tertile of age (<51 and <48 years, respectively). Our data indicate that the PC-1 121Q allele might predispose independently of other well established risk factors for early myocardial infarction. Testing for the PC-1 K121Q polymorphism might be valuable in patients with a family history of atherosclerotic vascular disease and myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12483464     DOI: 10.1007/s00109-002-0385-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  12 in total

1.  Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes.

Authors:  Salvatore De Cosmo; Antonio Minenna; Yuan-Yuan Zhang; Ryan Thompson; Robert Thompson; Giuseppe Miscio; Monica Vedovato; Anna Rauseo; Alois Saller; Sandra Mastroianno; Fabio Pellegrini; Roberto Trevisan; Paola Fioretto; Alessandro Doria; Vincenzo Trischitta
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

2.  Hepatic ENPP1 expression is induced in diabetic rabbits.

Authors:  Philipp Eller; Kathrin Hochegger; Andreas Wehinger; Ivan Tancevski; Wilfried Schgoer; Andreas Ritsch; Josef R Patsch
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

3.  The K121Q polymorphism of ENPP1 and peripheral arterial disease.

Authors:  Philipp Eller; Wilfried Schgoer; Thomas Mueller; Ivan Tancevski; Egon Demetz; Kristina Duwensee; Andreas Ritsch; Meinhard Haltmayer; Josef R Patsch
Journal:  Heart Vessels       Date:  2008-04-04       Impact factor: 2.037

4.  ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population.

Authors:  Miao-Pei Chen; Fu-Mei Chung; Dao-Ming Chang; Jack C-R Tsai; Han-Fen Huang; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2006-05-10

Review 5.  Insulin signaling regulating genes: effect on T2DM and cardiovascular risk.

Authors:  Sabrina Prudente; Eleonora Morini; Vincenzo Trischitta
Journal:  Nat Rev Endocrinol       Date:  2009-12       Impact factor: 43.330

Review 6.  Genetics of macrovascular complications in diabetes.

Authors:  Frédéric Fumeron; André F Reis; Gilberto Velho
Journal:  Curr Diab Rep       Date:  2006-04       Impact factor: 4.810

Review 7.  The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.

Authors:  Ira D Goldfine; Betty A Maddux; Jack F Youngren; Gerald Reaven; Domenico Accili; Vincenzo Trischitta; Riccardo Vigneri; Lucia Frittitta
Journal:  Endocr Rev       Date:  2008-01-16       Impact factor: 19.871

8.  Subsets of Finns with high HDL to total cholesterol ratio show evidence for linkage to type 2 diabetes on chromosome 6q.

Authors:  Corina Shtir; I Sharon Nagakawa; William L Duren; Karen N Conneely; Laura J Scott; Kaisa Silander; Timo T Valle; Jaakko Tuomilehto; Thomas A Buchanan; Richard N Bergman; Francis S Collins; Michael Boehnke; Richard M Watanabe
Journal:  Hum Hered       Date:  2006-12-14       Impact factor: 0.444

9.  Variants of insulin-signaling inhibitor genes in type 2 diabetes and related metabolic abnormalities.

Authors:  Carlo de Lorenzo; Annalisa Greco; Teresa Vanessa Fiorentino; Gaia Chiara Mannino; Marta Letizia Hribal
Journal:  Int J Genomics       Date:  2013-05-23       Impact factor: 2.326

10.  ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study.

Authors:  D Meyre; N Bouatia-Naji; V Vatin; J Veslot; C Samson; J Tichet; M Marre; B Balkau; P Froguel
Journal:  Diabetologia       Date:  2007-08-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.